Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study.

Seino, Yutaka; Fujita, Tetsuya; Hiroi, Shinzo; Hirayama, Masashi; Kaku, Kohei

Seino, Yutaka; Fujita, Tetsuya; Hiroi, Shinzo; Hirayama, Masashi; Kaku, Kohei.

Affiliation

Seino Y; Kansai Electric Power Hospital, Osaka, Japan. seino.yutake@e2.kepco.co.jp

Curr Med Res Opin ; 27(9): 1781-92, 2011 Sep.

Article in En | MEDLINE | ID: mdl-21806314

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Piperidines/administration & dosage; Piperidines/adverse effects; Uracil/analogs & derivatives; Aged; Algorithms; Asian People; Diabetes Mellitus, Type 2/ethnology; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents/administration & dosage; Hypoglycemic Agents/adverse effects; Male; Middle Aged; Placebos; Time Factors; Treatment Outcome; Uracil/administration & dosage; Uracil/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Uracil / Diabetes Mellitus, Type 2 Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Curr Med Res Opin Year: 2011 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google